Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease lupus erythematosus
Symptom C0040053|thrombosis
Sentences 9
PubMedID- 26090493 Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in china.
PubMedID- 23676348 Introduction: predicting thrombosis in patients with systemic lupus erythematosus (sle) and/or antiphospholipid antibodies (apl) is still challenging.
PubMedID- 22859353 Hydroxychloroquine (hcq) has been shown in retrospective studies to decrease apl titers in laboratory studies, and to decrease thrombosis risk in patients with systemic lupus erythematosus (sle).
PubMedID- 25661833 Subarachnoid hemorrhage and dural sinus thrombosis are important manifestations of neuropsychiatric lupus erythematosus.
PubMedID- 22193216 Reevaluation of predictive value of acl and anti-beta2gp1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world.
PubMedID- 25008944 Previous thrombosis, diagnosis of systemic lupus erythematosus (sle) and triple antiphospholipid (apl) antibody positivity have recently been found to be independent factors associated to pregnancy failure during conventional therapy in women with antiphospholipid syndrome (aps).
PubMedID- 25832953 Cerebral venous thrombosis as a complication of neuropsychiatric systemic lupus erythematosus.
PubMedID- 26075289 In particular, apl positivity has been identified as one of the main determinants of thrombosis among subjects with systemic lupus erythematosus (sle) .
PubMedID- 25117655 We investigated the relationship between tpo and the occurrence of thrombocytopenia and thrombosis in patients with systemic lupus erythematosus (sle).

Page: 1